TABLE 4.
Comparison of incidence of MACE among patients with different treatment regimens in matched cohort (%).
| Metabolic type | Therapeutic schedule | Number | Number of MACE (n) | Incidence of MACE (%) | χ 2 | P |
|---|---|---|---|---|---|---|
| EM type | Clop. | 104 | 7 | 6.73 | - | - |
| Tica. | 104 | 6 | 5.77 | 0.01 | 0.928 | |
| IM type | Clop. | 113 | 25 | 22.12 | - | - |
| Tica. | 113 | 13 | 11.50 | 4.55 | 0.033 | |
| PM type | Clop. | 40 | 12 | 30.00 | - | - |
| Tica. | 40 | 4 | 10.00 | 5.00 | 0.025 |
Data in this table are based on propensity score-matched cohorts. MACE: major adverse cardiovascular event.